Colorectal cancer tumor stem cells mediate bevacizumab resistance through the signal IL-22-STAT3 signaling pathway
Author:
Funder
Research project plan of Medical Science in Hebei Province
Publisher
Springer Science and Business Media LLC
Subject
Agricultural and Biological Sciences (miscellaneous),Environmental Science (miscellaneous),Biotechnology
Link
https://link.springer.com/content/pdf/10.1007/s13205-023-03742-5.pdf
Reference24 articles.
1. Benlahfid M, Traboulsi W, Sergent F et al (2018) Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis. Cancer Biomark 21:345–354. https://doi.org/10.3233/CBM-170499
2. Bruno S, Herrera Sanchez MB, Chiabotto G et al (2021) Human liver stem cells: a liver-derived mesenchymal stromal cell-like population with pro-regenerative properties. Front Cell Dev Biol 9:644088
3. Chou HH, Chen WC, Yang LY et al (2021) Postoperative adjuvant dose-dense chemotherapy with bevacizumab and maintenance bevacizumab after neoadjuvant chemotherapy for advanced ovarian cancer: a phase II AGOG/TGOG trial. Eur J Obstet Gynecol Reprod Biol 262:13–20. https://doi.org/10.1016/j.ejogrb.2021.04.017
4. Cui C, Chen X, Liu Y et al (2018) Galactosyltransferase v activates notch1 signaling in glioma stem-like cells and promotes their transdifferentiation into endothelial cells. J Biol Chem 293:2219–2230. https://doi.org/10.1074/jbc.RA117.000682
5. Fang C, Lin J, Zhang T et al (2021) Metastatic colorectal cancer patient with microsatellite stability and BRAFV600E mutation showed a complete metabolic response to PD-1 blockade and bevacizumab: a case report. Front Oncol 11:652394. https://doi.org/10.3389/fonc.2021.652394
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3